OP was speaking less about software and more about tech startup culture. Theranos comes to mind. Shoddy MVPs work well for consumer software but are dangerous i

OP was speaking less about software and more about tech startup culture. Theranos comes to mind. Shoddy MVPs work well for consumer software but are dangerous in the medical field where the results could be life or death. The question is how can existing processes help/hurt a transition to medical field or will it require a radically different approach that doesn't gain from existing expertise (or at least without thorough consideration).